In the current Model for End-Stage Liver Disease system, patients with polycystic liver disease (PCLD) who have a poor quality of life secondary to their massive hepatomegaly are no longer competitive for a deceased donor liver transplant if their liver function is well preserved. Traditionally, a caval resection has been advocated in these patients because of the difficulty of the hepatectomy with hepatomegaly, which makes living donation impossible. This series looks at 3 patients who underwent a caval sparing hepatectomy and subsequent living donor liver transplantation (LDLT) for PCLD. Graft and patient survival was 100%, and there were few complications in either donors or recipients. LDLT is an ideal option for patients with PCLD and preserved liver function but poor quality of life. © 2008 AASLD.
CITATION STYLE
Mekeel, K. L., Moss, A. A., Reddy, K. S., Douglas, D. D., Vargas, H. E., Carey, E. J., … Mulligan, D. C. (2008). Living donor liver transplantation in polycystic liver disease. Liver Transplantation, 14(5), 680–683. https://doi.org/10.1002/lt.21423
Mendeley helps you to discover research relevant for your work.